Heparin Adsorbed PTT

The heparin adsorbed PTT is a version of the activated partial thromboplastin time performed after the laboratory removes heparin from your plasma using a heparin-binding reagent. It evaluates how well the intrinsic and common pathways of your blood clotting system are working once the effect of heparin is taken out of the equation.

This test is typically done on citrate anticoagulated plasma. By comparing it with a routine aPTT, your care team can tell whether a prolonged clotting time is simply due to heparin in the sample or whether another issue, such as a clotting factor deficiency or an inhibitor, may be present.

Clinicians use this test when your routine aPTT is prolonged and you are receiving heparin therapy or there is concern that the blood sample may have been contaminated with heparin. Removing heparin helps clarify whether the prolongation is drug related or due to another condition.

This distinction guides next steps. If heparin is responsible, your team may adjust monitoring with drug-specific tests. If not, they may evaluate for conditions like lupus anticoagulant, specific factor deficiencies, liver disease, or other causes of abnormal clotting tests. Clear answers help tailor treatment while avoiding unnecessary changes to your anticoagulation.

If the clotting time returns to the expected range after heparin is adsorbed, the previous prolongation likely came from heparin therapy or contamination of the specimen. If it remains prolonged, another cause is likely, such as a factor deficiency, an inhibitor like a lupus anticoagulant, or a broader medical issue affecting clotting.

Your clinician may follow up with a mixing study, lupus anticoagulant testing, factor assays, or drug-specific levels. Interpretation depends on your medications, bleeding or clotting history, and other lab results. Do not stop or change any anticoagulant without medical advice; discuss your results and the appropriate next steps with your care team.